SWAT Team Description: The Clinical Development and Operations SWAT team collaborates on initiatives related to clinical operations (incl.  supporting trial site readiness and setting up a clinical trial site network, providing information on COVID-19 CTA and EC requirements for specific regions), vaccine safety (incl. AESIs / case definitions, post roll-out vaccine safety surveillance), vaccine science (incl. development of strategic documents on key topics such as standard CT elements, adaptive trial design, Correlate of Protection, alternative/supportive evidence, optimization options) and maternal immunization. 

Co-Leads: Peter Dull (BMGF), Jakob Cramer (CEPI)


COVAX > Clinical Development and Operation > Maternal Immunization

Maternal Immunization Working Group 

The COVAX MI WG, co-chaired by Drs. Flor M. Munoz (Baylor College of Medicine, USA) and Ros Hollingsworth (Bill & Melinda Gates Foundation, USA) includes a group of professionals with expertise in various aspects pertinent to maternal immunization, who represent diverse organizations, geographies, and settings. The aim of the MIWG is to enable the evaluation and utilization of COVID-19 vaccine candidates in pregnant and lactating women.

List of members [PDF 370kb]


How many countries / territories have policy positions on the use of COVID-19 vaccines in pregnancy?

Access relevant policies, documents and publications below:

Clinical Trials

Stay informed about the latest clinical trials and studies on maternal immunization

MI Vaccine Safety

Learn more about vaccine safety
for pregnant mothers and newborns

Policies and guidelines

Find out about policy, regulations and guidelines on maternal immunization wordwide


Explore our selection of relevant publications on COVID-19 maternal immunization

 To the TOP ↑

Working Group Details

Working Group Outputs



Read our newsletters for a synthesis of the latest information on COVID-19 vaccination and pregnancy:

June 2022

April 2022

October 2021

July 2021

 To the TOP ↑